Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2003
Postpartum thyroiditis is associated with fluctuations in transforming growth factor-beta1 serum levels
A Olivieri, S De Angelis, V Vaccari, et al.
Human Gene Therapy
|
April 12, 2018
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
Chiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, et al.
Molecular Therapy. Oncology
|
February 2, 2026
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells
Juliane Mietz, Lukas Egli, Meike Misiune, et al.
Oecologia
|
May 27, 2017
The relationship between tree height and leaf area: sapwood area ratio
N McDowell, H Barnard, B Bond, et al.
British Journal of Haematology
|
February 26, 2013
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
Sarah Tettamanti, Virna Marin, Irene Pizzitola, et al.
Molecular Cancer Therapeutics
|
March 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells
Laura G Volta, Celeste Gobbi, Christian Koch, et al.
Molecular Cancer Therapeutics
|
May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
Laura G Volta, Celeste Gobbi, Christian Koch, et al.
Oncoimmunology
|
October 8, 2024
Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors
Christian Pellegrino, Nicholas Favalli, Laura Volta, et al.
Oncotarget
|
June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
Chiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.
Molecular Therapy Oncolytics
|
August 16, 2023
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells
Chiara F Magnani, Renier Myburgh, Silvan Brunn, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2003
Postpartum thyroiditis is associated with fluctuations in transforming growth factor-beta1 serum levels
A Olivieri, S De Angelis, V Vaccari, et al.
Human Gene Therapy
|
April 12, 2018
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
Chiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, et al.
Molecular Therapy. Oncology
|
February 2, 2026
Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells
Juliane Mietz, Lukas Egli, Meike Misiune, et al.
Oecologia
|
May 27, 2017
The relationship between tree height and leaf area: sapwood area ratio
N McDowell, H Barnard, B Bond, et al.
British Journal of Haematology
|
February 26, 2013
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
Sarah Tettamanti, Virna Marin, Irene Pizzitola, et al.
Molecular Cancer Therapeutics
|
March 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells
Laura G Volta, Celeste Gobbi, Christian Koch, et al.
Molecular Cancer Therapeutics
|
May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
Laura G Volta, Celeste Gobbi, Christian Koch, et al.
Oncoimmunology
|
October 8, 2024
Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors
Christian Pellegrino, Nicholas Favalli, Laura Volta, et al.
Oncotarget
|
June 21, 2016
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
Chiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, et al.
Molecular Therapy Oncolytics
|
August 16, 2023
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells
Chiara F Magnani, Renier Myburgh, Silvan Brunn, et al.
Page
of 7